The John Vane Memorial Symposium on Prostacyclin Science and Pulmonary Vascular Disease was held at the Royal Society, London, UK again this year and it was wonderful to see everyone in person!
Those of you who attended will be able to revisit the presentations using the links below (your password has been emailed to you). We hope you enjoy.
Chris Thiemermann - Welcome
Anna Hemnes - Molecular Predictors of Prostacyclin Responses
Aaron Waxman - Inhaled Treprostinil in Pulmonary Hypertension due to Interstitial Lung Disease
Sussan Nourshargh - Inflammation & Neutrophil Trafficking: Novel Concepts
Roberto Badagliacca - Early and aggressive prostacyclin treatment in PAH
Raymond Benza - Remote Management of PAH and Risk Management
Olivier Sitbon - Portopulmonary Hypertension
Magdi Yaqoob - Pulmonary Hypertension in CKD: Where is the evidence?
Athenais Boucly - Initial Treatment Strategies and Survival in PAH
Murali Chakinala - Risk Stratification in PAH
Irene Lang - Defining PAH with Left Heart Phenotype
Ralph Schermuly - Kinase Signalling in Pulmonary Hypertension
Robert Naeije - Imaging of the right ventricle for risk assessment and treatment in PAH
Thomas Cascino - Upfront Triple Therapy in Pulmonary Hypertension
Jim White - Emerging Clinical Studies
